Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurotensin | 9 | 2019 | 37 | 2.030 |
Why?
|
| Peptide Fragments | 7 | 2010 | 483 | 1.580 |
Why?
|
| Oligopeptides | 9 | 2019 | 152 | 1.300 |
Why?
|
| Receptors, Neurotensin | 10 | 2019 | 17 | 1.200 |
Why?
|
| Hypothermia, Induced | 8 | 2019 | 93 | 0.940 |
Why?
|
| Analgesics | 2 | 2019 | 118 | 0.930 |
Why?
|
| Opioid Peptides | 1 | 2019 | 17 | 0.670 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2019 | 37 | 0.660 |
Why?
|
| Pain | 2 | 2020 | 472 | 0.660 |
Why?
|
| Neuroprotective Agents | 4 | 2019 | 317 | 0.450 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2005 | 306 | 0.430 |
Why?
|
| Infarction, Middle Cerebral Artery | 3 | 2019 | 105 | 0.420 |
Why?
|
| Rats | 10 | 2019 | 5300 | 0.380 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2019 | 2083 | 0.360 |
Why?
|
| Body Temperature | 5 | 2019 | 116 | 0.350 |
Why?
|
| Blood-Brain Barrier | 3 | 2020 | 99 | 0.320 |
Why?
|
| Animals | 18 | 2020 | 20881 | 0.290 |
Why?
|
| Motor Activity | 3 | 2016 | 621 | 0.270 |
Why?
|
| Lysine | 1 | 2005 | 96 | 0.250 |
Why?
|
| Curcumin | 1 | 2005 | 23 | 0.250 |
Why?
|
| Arginine | 1 | 2005 | 102 | 0.250 |
Why?
|
| Antipsychotic Agents | 1 | 2005 | 247 | 0.220 |
Why?
|
| Recovery of Function | 4 | 2019 | 506 | 0.190 |
Why?
|
| Brain Injuries | 2 | 2015 | 268 | 0.190 |
Why?
|
| Drug Discovery | 1 | 2022 | 94 | 0.190 |
Why?
|
| Triazoles | 1 | 2020 | 43 | 0.180 |
Why?
|
| Receptors, Opioid | 1 | 2020 | 60 | 0.180 |
Why?
|
| Lung | 1 | 2005 | 849 | 0.170 |
Why?
|
| Binding, Competitive | 2 | 2010 | 165 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2015 | 1745 | 0.170 |
Why?
|
| Brain Ischemia | 2 | 2017 | 665 | 0.160 |
Why?
|
| Structure-Activity Relationship | 2 | 2010 | 420 | 0.160 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2019 | 72 | 0.160 |
Why?
|
| Locomotion | 1 | 2019 | 135 | 0.160 |
Why?
|
| Administration, Oral | 1 | 2019 | 411 | 0.150 |
Why?
|
| Male | 12 | 2019 | 37321 | 0.150 |
Why?
|
| Middle Cerebral Artery | 1 | 2017 | 57 | 0.140 |
Why?
|
| Cell Polarity | 1 | 2016 | 49 | 0.140 |
Why?
|
| Microfilament Proteins | 2 | 2016 | 102 | 0.130 |
Why?
|
| Calcium | 2 | 2010 | 929 | 0.130 |
Why?
|
| Cell Line | 2 | 2010 | 1752 | 0.130 |
Why?
|
| Microglia | 1 | 2016 | 143 | 0.130 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 239 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1070 | 0.120 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 2550 | 0.120 |
Why?
|
| Cell Movement | 1 | 2016 | 630 | 0.110 |
Why?
|
| Half-Life | 2 | 2003 | 96 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 2791 | 0.110 |
Why?
|
| Myxoma | 1 | 2012 | 17 | 0.100 |
Why?
|
| Contractile Proteins | 1 | 2012 | 17 | 0.100 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2012 | 24 | 0.100 |
Why?
|
| Mitral Valve Prolapse | 1 | 2012 | 40 | 0.100 |
Why?
|
| Cytokines | 1 | 2016 | 866 | 0.100 |
Why?
|
| Cerebral Infarction | 1 | 2012 | 103 | 0.100 |
Why?
|
| Mitral Valve | 1 | 2012 | 166 | 0.100 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2016 | 160 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 1083 | 0.090 |
Why?
|
| Mice | 6 | 2017 | 8474 | 0.090 |
Why?
|
| Radioligand Assay | 1 | 2010 | 109 | 0.090 |
Why?
|
| Drug Tolerance | 1 | 2010 | 80 | 0.090 |
Why?
|
| Aminopeptidases | 1 | 2009 | 6 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2009 | 42 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2010 | 328 | 0.080 |
Why?
|
| Brain | 1 | 2019 | 2176 | 0.080 |
Why?
|
| Time Factors | 3 | 2015 | 4655 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 2223 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 765 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 596 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2673 | 0.070 |
Why?
|
| Catalepsy | 1 | 2005 | 8 | 0.070 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2016 | 35 | 0.060 |
Why?
|
| Dextroamphetamine | 1 | 2005 | 30 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 1 | 2005 | 89 | 0.060 |
Why?
|
| Biological Availability | 1 | 2005 | 79 | 0.060 |
Why?
|
| Haloperidol | 1 | 2005 | 95 | 0.060 |
Why?
|
| Carbon Radioisotopes | 1 | 2005 | 34 | 0.060 |
Why?
|
| Diarylheptanoids | 1 | 2005 | 3 | 0.060 |
Why?
|
| Caco-2 Cells | 1 | 2005 | 37 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2005 | 238 | 0.060 |
Why?
|
| Bleomycin | 1 | 2005 | 67 | 0.060 |
Why?
|
| Hypothermia | 1 | 2005 | 37 | 0.060 |
Why?
|
| Drug Design | 1 | 2005 | 107 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 181 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2016 | 371 | 0.060 |
Why?
|
| Sodium | 1 | 2005 | 161 | 0.060 |
Why?
|
| Humans | 6 | 2020 | 68618 | 0.060 |
Why?
|
| Stroke | 1 | 2017 | 2163 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 381 | 0.060 |
Why?
|
| Drug Stability | 1 | 2003 | 71 | 0.060 |
Why?
|
| Phosphatidylinositols | 1 | 2003 | 40 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 314 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 618 | 0.060 |
Why?
|
| COS Cells | 1 | 2003 | 155 | 0.060 |
Why?
|
| Pulmonary Fibrosis | 1 | 2005 | 157 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2005 | 221 | 0.050 |
Why?
|
| Amino Acids | 1 | 2003 | 131 | 0.050 |
Why?
|
| Calibration | 1 | 2002 | 73 | 0.050 |
Why?
|
| Azides | 1 | 2002 | 56 | 0.050 |
Why?
|
| Reference Standards | 1 | 2002 | 115 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 358 | 0.050 |
Why?
|
| Transfection | 1 | 2003 | 782 | 0.050 |
Why?
|
| Neurons | 2 | 2016 | 881 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2002 | 737 | 0.050 |
Why?
|
| Neurovascular Coupling | 1 | 2019 | 9 | 0.040 |
Why?
|
| Protein Binding | 1 | 2002 | 1027 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 397 | 0.040 |
Why?
|
| Resuscitation | 1 | 2019 | 77 | 0.040 |
Why?
|
| Ventricular Fibrillation | 1 | 2019 | 85 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2019 | 113 | 0.040 |
Why?
|
| Ice | 1 | 2016 | 13 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 114 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 176 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 137 | 0.030 |
Why?
|
| Hypoxia | 1 | 2016 | 169 | 0.030 |
Why?
|
| Blood-Testis Barrier | 1 | 2015 | 2 | 0.030 |
Why?
|
| Cell Death | 1 | 2016 | 329 | 0.030 |
Why?
|
| Glucose | 1 | 2016 | 307 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 88 | 0.030 |
Why?
|
| Oxygen | 1 | 2016 | 386 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 174 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2015 | 233 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 160 | 0.030 |
Why?
|
| Heart Rate | 1 | 2016 | 568 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 396 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 209 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 415 | 0.030 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2012 | 5 | 0.030 |
Why?
|
| Filamins | 1 | 2012 | 17 | 0.030 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 51 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 1738 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 626 | 0.030 |
Why?
|
| Transglutaminases | 1 | 2012 | 67 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2014 | 954 | 0.030 |
Why?
|
| Serotonin | 1 | 2012 | 144 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1174 | 0.020 |
Why?
|
| Motor Skills | 1 | 2012 | 88 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2012 | 231 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2012 | 296 | 0.020 |
Why?
|
| Autophagy | 1 | 2012 | 208 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 1692 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 7029 | 0.020 |
Why?
|
| Apoptosis | 1 | 2012 | 1641 | 0.020 |
Why?
|